Patents Assigned to ALSGEN, INC.
  • Modulation of Neurodegenerative Diseases Through The Progesterone Receptor
    Publication number: 20090062245
    Abstract: Methods for modulating hormonal pathways involving the progesterone receptor in a subject with a neurodegenerative disorder, are provided. Progesterone receptor activity is modulated by administering an effective amount of an progesterone receptor modulating pharmacological agent to a subject such that the progesterone receptor modulating pharmacological agent interacts with the progesterone receptor and alters the expression of a protein associated with the neurodegenerative disease.
    Type: Application
    Filed: October 21, 2008
    Publication date: March 5, 2009
    Applicant: ALSGEN, INC.
    Inventors: Sean Scott, Daniel Benjamin
  • Modulation of neurodegenerative diseases
    Publication number: 20070135437
    Abstract: Methods and compositions are disclosed for selectively decreasing protein levels in a central nervous system, meningial, immune system, blood, or muscle cell by administrating a pharmacological agent. In particular, methods and compositions that interfere with SOD-1 protein synthesis or stability, and decrease cellular levels of the protein are disclosed.
    Type: Application
    Filed: November 28, 2006
    Publication date: June 14, 2007
    Applicant: ALSGEN, INC.
    Inventors: Daniel Benjamin, Robert Henrie, Monica Errico, Brian Rex, Justin Bracken, Sean Scott